Galera Therapeutics, Inc. (GRTX) Operating Income (Loss) USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Galera Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
  • Galera Therapeutics, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$4.58 M, a 67% increase year-over-year.
  • Galera Therapeutics, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$40 M, a 23.1% increase year-over-year.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$49.3 M, a 3.84% increase from 2022.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$51.2 M, a 30.2% increase from 2021.
  • Galera Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$73.4 M, a 3.99% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$40 M -$4.58 M +$9.3 M +67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$49.3 M -$5.18 M +$8.01 M +60.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 -$57.3 M -$13.4 M -$438 K -3.38% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$56.8 M -$16.8 M -$4.88 M -40.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$52 M -$13.9 M -$727 K -5.53% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$51.2 M -$13.2 M +$1.31 M +9.06% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 -$52.5 M -$13 M +$7.34 M +36.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$59.9 M -$11.9 M +$9.16 M +43.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$69 M -$13.2 M +$4.33 M +24.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$73.4 M -$14.5 M +$4.45 M +23.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 -$77.8 M -$20.3 M -$4.22 M -26.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$73.6 M -$21.1 M -$3.38 M -19.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$70.2 M -$17.5 M +$337 K +1.89% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$70.6 M -$18.9 M -$2.78 M -17.2% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$67.8 M -$16.1 M -$3.22 M -25.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$64.6 M -$17.7 M -$6.44 M -57.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$58.1 M -$17.8 M -$7.42 M -71.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 -$50.7 M -$16.2 M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$12.9 M -$7.45 M -138% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$11.3 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$10.4 M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 -$5.41 M Jul 1, 2018 Sep 30, 2018 10-Q 2019-12-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.